Advertisement

Topics

Sage shares rise after postpartum depression drug meets main goal

07:51 EST 9 Nov 2017 | Reuters

(Reuters) - Sage Therapeutics on Thursday said its drug to treat moderate and severe postpartum depression succeeded in reducing symptoms in patients enrolled in two late-stage trials, sending its shares up 50 percent in pre-market trade.

Original Article: Sage shares rise after postpartum depression drug meets main goal

NEXT ARTICLE

More From BioPortfolio on "Sage shares rise after postpartum depression drug meets main goal"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...

Depression
Depression is a serious mental health condition, where sad feelings carry on for weeks or months and interfere with your life. The symptoms include feeling unhappy most of the time (but may feel a little better in the evenings), loosing interest in lif...